BacterioScan
St. Louis, US · Founded 2010 · Delaware corporation
Find your way into BacterioScan
48 people in our graph share verified history with the BacterioScan team — schools, employers, funds. One of them is your warm intro.
Tom Danilekunlockedknows Dana A. Marshall · together at University of Michigan (overlapped)
×10knows the team · via University of Michigan
knows the team · via Specific Diagnostics
Bacterioscan develops diagnostic technologies and solutions for bacterial detection and identification. The company serves healthcare, pharmaceutical, and diagnostics markets.
Founders & leadership
DA
Dana A. MarshallinPresident and Chief Executive OfficerDana A. Marshall is President and CEO of BacterioScan, which develops diagnostic technologies for bacterial detection and identification. He has over 30 U.S. patents in medical devices, in-vitro diagnostics, lasers and optics, and photonic instrumentation, with prior experience in clinical, aerospace, defense, and manufacturing sectors.
ME
Michael E. Thaman, Sr.CEO & Chairman of the Board
RS
Rhonda SoestDirector of Marketing
Board
ME
Michael E. ThamanBoard director
AW
Amnon WeischelbaumBoard director
RR
Richard R. VietorBoard director
JB
James Brigham, Jr.Board director
WR
William R. MarshallBoard director
MB
Moshe BarkenBoard director
Reported raises · per SEC filings
Form D private placements$7.4M disclosed across 2 rounds · 2013–2015
▶$1.7MraisedAug 2015 · 7 investors · Other TechnologyRule 506(b)
▶$1.7MraisedAug 2015 · 7 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Richard R. VietorDirector
- Greg HewettDirector
- Moshe BarkanDirector
- Michael E. ThamanExecutive Officer, Director
- Dana MarshallExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $1.7M
- First sale
- Jul 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.7MraisedFeb 2015 · 7 investors · BiotechnologyRule 506(b)
▶$5.7MraisedFeb 2015 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael E. ThamanDirector
- Amnon WeischelbaumDirector
- Richard R. VietorDirector
- James Brigham, Jr.Director
- William R. MarshallDirector
- Dana A. MarshallExecutive Officer
- Moshe BarkenDirector
- Rhonda SoestExecutive Officer
- Offering amount
- $6M
- Amount sold
- $5.7M
- Minimum investment
- $150K
- First sale
- May 2013
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapWorld Health Organization, 202521 shared keywordsThe World Health Organization is a United Nations agency founded in 1948 that leads global health initiatives and emergency response across 194 member states. It works to expand universal health coverage, coordinate responses to health emergencies, and promote healthier lives across all life stages.
UPMC21 shared keywordsUPMC is a regional healthcare provider that invests in community health through charity care, free and subsidized health programs, and support for seniors, veterans, and food-insecure populations.
Companies competing with BacterioScan for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $210.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does BacterioScan do?
- Bacterioscan develops diagnostic technologies and solutions for bacterial detection and identification. The company serves healthcare, pharmaceutical, and diagnostics markets.
- How much funding has BacterioScan raised?
- BacterioScan has disclosed $7.4M raised across 2 rounds.
- Where is BacterioScan headquartered?
- BacterioScan is headquartered in St. Louis, US.